ILC2 Cancer Research Results

ILC2, Group 2 Innate Lymphoid Cells: Click to Expand ⟱

Source:

Type:

ILC2 - Group 2 Innate Lymphoid Cells

Type: Innate immune-cell population / type-2 immune effector cells

Function: ILC2 cells are innate lymphoid cells strongly activated by IL-33 through ST2/IL1RL1. Activated ILC2 cells produce cytokines including IL-5 and IL-13 and regulate eosinophils, macrophage polarization, dendritic-cell function, tissue repair, and type-2 immune responses.

Cancer: ↕ Context-dependent. ILC2 cells can promote tumor-supportive type-2 inflammation and immunosuppression in some tumors but can also enhance antitumor immunity by supporting dendritic-cell activation, cytotoxic T-cell responses, eosinophils, and other immune-effector populations.

Scientific Papers found: Click to Expand⟱

7928-

H2,

Molecular hydrogen alleviates asthma through inhibiting IL-33/ILC2 axis

in-vivo,

Asthma,

 OVA sensitized asthma mouse model

*IL33↓, *NF-kB↓, *IL1RL1/ST2↓, *ILC2↓, *E-cadherin↑, *ZO-1↑, *Inflam↓,

Showing Research Papers: 1 to 1 of 1

* indicates research on normal cells as opposed to diseased cells
Total Research Paper Matches: 1

Pathway results for Effect on Cancer / Diseased Cells:

Total Targets: 0

Pathway results for Effect on Normal Cells:

NA, unassigned(tgid=0) ⓘ

IL1RL1/ST2↓, 1, ILC2↓, 1,

Migration(tgid=13) ⓘ

E-cadherin↑, 1, ZO-1↑, 1,

Immune & Inflammatory Signaling(tgid=16) ⓘ

IL33↓, 1, Inflam↓, 1, NF-kB↓, 1,
Total Targets: 7

Scientific Paper Hit Count for: ILC2, Group 2 Innate Lymphoid Cells

Query results interpretion may depend on "conditions" listed in the research papers.
Such Conditions may include : 
  -low or high Dose
  -format for product, such as nano of lipid formations
  -different cell line effects
  -synergies with other products 
  -if effect was for normal or cancerous cells